Welcome to the Department of Pathology
The Department of Pathology at Yale was one of the first departments organized at Yale School of Medicine and has a long and distinguished tradition of world-renowned clinical care, cutting-edge scientific research, and rigorous training of the next generation of pathologists to be leaders in their field. Pathology at Yale has many “firsts” to its credit, including leadership in documenting the pathology of pandemic flu, radiation injury, and environmental lung disease; methods for the diagnosis and assessment of lymphoproliferative disorders and genomic pathways of tumor resistance to targeted therapeutics. With our robust research investigations, teaching programs and clinical patient care, we are able to bring new knowledge and innovative therapeutic approaches to our patients and to medicine. Our dedication to excellence in both the clinical and the academic arenas is paramount to our mission as a Department and to our long tradition at Yale of introducing leading technologies for the benefit of patient care.
Yale Pathology is located in the center of a vigorous academic hub and part of the Yale-New Haven Health System with its multiple campuses. We are also a critical partner with Yale’s Comprehensive Cancer Center and the Smilow Cancer Hospital. Our medical and research faculty are embedded in an academic and clinical environment with a rich and diverse array of state-of-the-art resources and expert multi-disciplinary teams available for consultation.
In our continuing commitment to outstanding patient care, our diagnostic clinical programs and services offer patients the most accurate, most advanced, safest, and most cost-effective pathology and laboratory evaluations available. We now offer, in conjunction with the Smilow Cancer Hospital and with Yale’s Center for Genome Analysis, a multi-tiered and cost-effective approach to the genomic analysis of patients with cancer and performed at a level of analysis and evaluation of the variants detected and their therapeutic implications is nearly unprecedented in a clinical laboratory. We are significantly expanding the genotyping service to meet the explosive growth in demand for these services.
Recent advances from our bioscience research laboratories include basic discoveries in mapping the epigenetic basis of tumor progression; novel genetic and epigenetic screening methodologies that promise new methods of detecting occult tumors in the pancreas and colon; new insights into the many ways that tumors achieve their aggressive growth; gene-detection methodologies that have revolutionized our assessment of lymphoproliferative disorders; novel concepts of breast cancer initiation, progression, and diagnosis that are central to guiding therapy for patients with breast cancer; widespread institution of advanced molecular techniques for cervical cancer risk detection, the detection of sexually transmitted infections; and the development of innovative and promising approaches to vaccine development for viral diseases.
To continue our long tradition of education, our medical staff’s primary teaching focus is our graduate medical education program, which is tailored to train the next generation of pathologists. Our resident training in pathology is accredited by ACGME. The teaching focus of our research faculty is our Ph.D program, designed to train future scientists in their field. An integral aspect of these programs is to train our residents and graduate students to be teachers and to perpetuate this role so central to their profession and career. Our graduates practice throughout the world, often assuming research and clinical leadership roles at academic and teaching centers.
We are committed to a future as rich and dynamic as our heritage as been, and we welcome you to our web site, where you may learn more about our Department. You will find information on our upcoming lectures and seminars in our Pathology Calendar.
Jon. S. Morrow, M.D., Ph.D.
Raymond Yesner Professor of Pathology
Chair, Department of Pathology
Yale School of Medicine
Chief of Pathology, Yale-New Haven Hospital